Cargando…

Increased Risk of Urinary Tract Cancer in ESRD Patients Associated with Usage of Chinese Herbal Products Suspected of Containing Aristolochic Acid

INTRODUCTION: Both end-stage renal disease (ESRD) and urothelial cancer (UC) are associated with the consumption of Chinese herbal products containing aristolochic acid (AA) by the general population. The objective of this study was to determine the risk of UC associated with AA-related Chinese herb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuo-Meng, Lai, Ming-Nan, Wei, Alan, Chen, Ya-Yin, Pu, Yeong-Shiau, Chen, Pau-Chung, Wang, Jung-Der
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149424/ https://www.ncbi.nlm.nih.gov/pubmed/25170766 http://dx.doi.org/10.1371/journal.pone.0105218

Ejemplares similares

Population-Based Case–Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk
por: Lai, Ming-Nan, et al.
Publicado: (2010)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice
por: Quan, Yi, et al.
Publicado: (2020)

Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis
por: Jhuang, Jing-Rong, et al.
Publicado: (2019)

«Suspects» in Etiology of Endemic Nephropathy: Aristolochic Acid versus Mycotoxins
por: Pepeljnjak, Stjepan, et al.
Publicado: (2010)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
por: Chiou, Yueh-Er, et al.
Publicado: (2020)

Increased Upper and Lower Tract Urothelial Carcinoma in Patients with End-Stage Renal Disease: A Nationwide Cohort Study in Taiwan during 1997–2008
por: Wang, Shuo-Meng, et al.
Publicado: (2014)

Chinese Herbs Containing Aristolochic Acid Associated with Renal Failure and Urothelial Carcinoma: A Review from Epidemiologic Observations to Causal Inference
por: Yang, Hsiao-Yu, et al.
Publicado: (2014)

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
por: Chen, Chung-Hsin, et al.
Publicado: (2016)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003
por: Hsieh, Shu-Ching, et al.
Publicado: (2008)

An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids
por: Wu, Lan, et al.
Publicado: (2015)

Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents
por: Li, Xi-Lin, et al.
Publicado: (2020)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

Ureteral Involvement and Diabetes Increase the Risk of Subsequent Bladder Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
por: Hu, Che-Yuan, et al.
Publicado: (2015)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Effect of Insurance on Prescription Drug Use by ESRD Beneficiaries
por: Shih, Ya-chen Tina
Publicado: (1999)

Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
por: Lim, Abner Herbert, et al.
Publicado: (2022)

Urinary Tubular Injury Biomarkers Are Associated With ESRD and Death in the REGARDS Study
por: Dubin, Ruth F., et al.
Publicado: (2018)

The role of herbal medicines in treatment of urinary tract diseases
por: Gohari, Ahmad-Reza, et al.
Publicado: (2014)

Use of Home Health Care by ESRD and Medicare Beneficiaries
por: Kauf, Teresa L., et al.
Publicado: (1999)

Recent developments in detoxication techniques for aristolochic acid-containing traditional Chinese medicines
por: Fan, Yang, et al.
Publicado: (2020)

Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies
por: Kang, Yu-Chan, et al.
Publicado: (2021)

Lower Mortality in Living Kidney Donors With ESRD Versus Matched Nondonors With ESRD
por: Muzaale, Abimereki D.
Publicado: (2018)

Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo
por: TAO, LE, et al.
Publicado: (2015)

Increased Lifetime Risk of ESRD in Familial IgA Nephropathy
por: Shi, Manman, et al.
Publicado: (2020)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF
por: Guo, Yanhong, et al.
Publicado: (2022)

Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood
por: Chen, Shuzhen, et al.
Publicado: (2022)

Iron status in ESRD patients
por: Wiwanitkit, V.
Publicado: (2011)

The Tragedy of Having ESRD in Mexico
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2018)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Evaluation of antimicrobial prescriptions in dogs with suspected bacterial urinary tract disease
por: Weese, Jeffrey Scott, et al.
Publicado: (2021)

Antibiotic prescription patterns in patients with suspected urinary tract infections in Ecuador
por: Sánchez, Xavier, et al.
Publicado: (2023)

Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
por: Yi, Joo-Hark, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tn3ubanncjkru3agsdfhankgfd